Concurrent chemoradiotherapy with weekly versus three-weekly cisplatin in locally advanced head and neck squamous cell carcinoma
Editorial Group: Cochrane Ear, Nose and Throat Disorders Group
Published Online: 10 JAN 2014
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Shivakumar T, Nair S, Gupta T, Kannan S. Concurrent chemoradiotherapy with weekly versus three-weekly cisplatin in locally advanced head and neck squamous cell carcinoma (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD010906. DOI: 10.1002/14651858.CD010906.
- Publication Status: New
- Published Online: 10 JAN 2014
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the efficacy of a weekly cisplatin regimen compared to a three-weekly regimen, given with curative intent to treat locally advanced HNSCC, in terms of overall survival (at five years).
To assess the distant metastasis-free survival (at two years), disease-free survival (at two years) and the toxicity profile of the two regimens.